Full text loading...
n SA Pharmaceutical Journal - New product focus : drug info
USD
Abstract
Rheumalef® (leflunomide) is indicated for the treatment of adult patients with active rheumatoid arthritis (RA) as a 'disease-modifying antirheumatic drug' (DMARD) and to improve physical function.
©
Publisher
Article metrics loading...
/content/mp_sapj/83/5/EJC192357
2016-01-01
2017-06-29